Treatment of actinomycetoma due to Nocardia spp. with amoxicillin- clavulanate

British Journal of Dermatology

Volumn 156, Issue 2, 2007, Pages 308-311

  Bonifaz, A ^a   Flores, P ^b   Saul A ^b   Carrasco Gerard, E ^a   Ponce, R M ^b  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Actinomycetoma; Co amoxiclav; Mycetoma; Nocardia brasiliensis; Nocardia sp.

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; DAPSONE; KANAMYCIN; RIFAMPICIN; STREPTOMYCIN;

ABSENCE OF SIDE EFFECTS; ACTINOMYCETOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; MICROBIOLOGICAL EXAMINATION; MULTIPLE CYCLE TREATMENT; NOCARDIA; NOCARDIA ASTEROIDES; NOCARDIA BRASILIENSIS; NOCARDIA OTITIDISCAVIARUM; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AGED; AMIKACIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; DAPSONE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; MALE; MEXICO; MIDDLE AGED; NOCARDIA INFECTIONS; RETROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; TREATMENT OUTCOME;

EID: 33846216391     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07557.x     Document Type: Article

References (19)

1. McGinnis M. Mycetoma. Dermatol Clin 1996; 14:97-104.
2. Magaña M, Magaña-García M. Mycetoma. Dermatol Clin 1989; 7:203-17.
3. Lavalle P. Mycetoma. In: Clinical Tropical Dermatology (Canizares O, Harman RR, eds), 2nd edn. Boston: Blackwell Scientific Publications, 1992; 41-90.
4. Buot G, Lavalle P, Mariat F, Suchil P. Étude épidé miologique des mycetomas au Mexique. A propos de 502 cas. Bull Soc Pathol Exot Filiales 1987; 80:329-39.
5. López-Martínez R, Mendez-Tovar LJ, Lavalle P et al. Epidemiología del micetoma en México: estudio de 2105 casos. Gac Med Mex 1992; 128:477-81.
6. Welsh O, Salinas MC, Rodríguez MA. Treatment of eumycetoma and actinomycetoma. Curr Top Med Mycol 1995; 6:47-71.
7. Gómez A, Saúl A, Bonifaz A, López M. Amoxicillin and clavulanic acid in the treatment of actinomycetoma. Int J Dermatol 1993; 32:218-20.
8. Katar ML, Al-Halali HM, Fouad-Khalid M et al. Mycetoma in Yemen: clinicoepidemiologic and histopathologic study. Int J Dermatol 2002; 41:586-93.
9. Dieng MT, Niang SO, Diop B, Ndiaye B. Actinomycetomas in Senegal. Study of 90 cases. Bull Soc Pathol Exot Filiales 2005; 98:18-20.
10. Boiron P, Locci R, Goodfellow M et al. Nocardia, nocardiosis and mycetoma. Med Mycol 1998; 36 (Suppl. 1):26-37.
11. Welsh O. Mycetoma. Current concepts in treatment. Int J Dermatol 1991; 30:387-98.
12. Poncio-Mendes R, Negroni R, Bonifaz A, Pappagianis D. New aspects of some endemic mycoses. Med Mycol 2000; 38 (Suppl. 1):237-41.
13. Welsh O, Sauceda E, González J, Ocampo J. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J Am Acad Dermatol 1987; 17:443-8.
14. Wallace RJ, Steele LC. Susceptibility testing of Nocardia species for the clinical laboratory. Diagn Microbiol Infect Dis 1988; 9:155-66.
15. Boiron P, Provost F. In-vitro susceptibility testing of Nocardia spp. and its taxonomic implication. J Antimicrob Chemother 1988; 22:623-9.
16. Gómez-Flores A, Welsh O, Said-Fernández S et al. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother 2004; 48:823-7.
17. Steingrube VA, Wallace Jr RJ, Brown BA et al. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in betalactamase following therapy with amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1999; 35:524-8.
18. Barton LL. Lymphocutaneous Nocardia brasiliensis infection in children. Pediatr Infect Dis J 2000; 19:1023-5.
19. Stasiecki P, Diehl V, Vlaho M et al. New effective therapy of systemic infection with Nocardia asteroides. Dtsch Med Wochenschr 1985; 110:1733-7.